RUDN is developing partnerships with Medis pharmaceutical company (Tunisia)
RUDN CCU strengthens international cooperation with foreign companies. The successful experience of the “full cycle” from pharmaceutical development to the commercialization of the finished medicinal product with Medis has become a platform for new ideas and plans of partner organizations.
The interest of the Tunisian company was evoked by the ongoing projects of RUDN in the field of personalized medicine and the possibility of conducting research on bioequivalence based on the CCU and clinical trials of oncological drugs based on the project partners’ sites (Moscow Herzen Research Oncological Institute).
The CCU can in the future serve as a platform for the implementation of the “industrial” PhD program, having a modern instrumentation park and a training and production site with a license to produce drugs: the company sends its employee to graduate school, after graduation the employee returns and implements the results of his or her research in production. At the moment, agreements have been reached on the exchange of scientific knowledge in the field of X-ray diffraction analysis, NMR spectroscopy, melt extrusion, and metabolomics in online consultation mode and in the framework of further education programs.
September 22, a cooperation agreement was signed between RUDN and ZAO “Evalar”, the largest Russian manufacturer of natural drugs and biologically active food supplements. The document was signed by Andrei Kostin, RUDN Vice rector for Research, and Prokopyeva Natalia, the chairman boards of directors JSC “EVALAR”.
On September 27 the minister of science and the highest educations Valery Nikolaevich Falkov declared the list of the participating organizations of the Priority 2030 program. Demands were created by 191 higher education institution, the total list entered only 106 higher education institutions.
The document was signed on 6 July in Dubna during a visit of a leadership delegation of the Peoples’ Friendship University of Russia (RUDN University) to JINR. The agreement provides joint training of staff in the fields of physics, mathematics, IT, and life sciences, as well as cooperation in the realm of research activities with the use of JINR’s unique equipment.
September 22, a cooperation agreement was signed between RUDN and ZAO “Evalar”, the largest Russian manufacturer of natural drugs and biologically active food supplements. The document was signed by Andrei Kostin, RUDN Vice rector for Research, and Prokopyeva Natalia, the chairman boards of directors JSC “EVALAR”.
On September 27 the minister of science and the highest educations Valery Nikolaevich Falkov declared the list of the participating organizations of the Priority 2030 program. Demands were created by 191 higher education institution, the total list entered only 106 higher education institutions.
The document was signed on 6 July in Dubna during a visit of a leadership delegation of the Peoples’ Friendship University of Russia (RUDN University) to JINR. The agreement provides joint training of staff in the fields of physics, mathematics, IT, and life sciences, as well as cooperation in the realm of research activities with the use of JINR’s unique equipment.